Although OGTT was not performed due to hypoglycemia risk, the diagnosis of acromegaly was supported by sustained IGF-1 elevation, characteristic physical findings, a pituitary macroadenoma on MRI, and histopathological confirmation of GH secretion postoperatively. This evidence concerns the gene IGF1 and acromegaly.